CALIFORNIA BIOTECH &lt;CBIO> SEES 1ST QTR LOSS California Biotechnology expects report loss 1,300,000 dlrs 1,600,000 dlrs quarter due increased investment research manufacturing scaleup production. company research spending running 50 60 pct year ago commercialize products quickly possible, increased expenditures expected continue quarters. operating results fluctuate quarter quarter, depending timing significant payments commercial partners. months 1986, company lost 150,000 dlrs. company changed fiscal year 1986 calendar year year ending November 30. quarter year, ended February 28, California Biotech earned 114,000 dlrs.